For the Inventor, By the Inventor

Enter assignee name

Canadian Blood Services

Calculating rank

USPTO Granted Patents = 33

% Expired Patents = 60.6

CIPO Patents = 10

EPO Patents = 26

Forward Citations = 97

Loading Chart...

Loading Chart...

37 inventors (with patents filed for the assignee):

Elisabeth Maurer (9 out of 13 patents)

Mark D Scott (9 out of 11 patents)

Duncheng Wang (5 out of 7 patents)

4. Wendy M Toyofuku (5 out of 7 patents)

5. Alan H Lazarus (3 out of 3 patents)

6. John Freedman (3 out of 3 patents)

7. Andrew R Crow (3 out of 3 patents)

8. Donald R Branch (2 out of 4 patents)

9. William Peter Sheffield (2 out of 3 patents)

10. Sandra M Ramirez-Arcos (2 out of 2 patents)

11. Georg Maurer (2 out of 2 patents)

12. Keddie Brown (2 out of 4 patents)

13. Heyu Ni (2 out of 3 patents)

14. Guangheng Zhu (2 out of 2 patents)

15. Edward L G Pryzdial (2 out of 2 patents)

Core Competencies:

Pyrazole Derivatives

Acellular Compositions

Factor XIa Aptamers

Immune Tolerance

Dynamic Light Scattering

Platelet Additive Solution

Graft Rejection

Autoimmune Diseases

Coagulation Proteins

Viral Infection Detection

Platelet Quality

HLA Alloimmune Response

33 patents: Sort by Forward Citations

1. 11090288 - Pyrazole derivatives and their uses thereof (2021-08-17),

2. 11007221 - Acellular pro-inflammatory compositions, process for making same and methods of using same (2021-05-18),

3. 10494634 - Factor XIa-specific aptamers (2019-12-03),

4. 10188681 - Method for inducing immune tolerance using non-proliferative polymer-modified allogeneic leukocytes (2019-01-29),

5. 10130609 - Pyrazole derivatives and their uses thereof (2018-11-20),

6. 10039788 - Acellular pro-tolerogenic compositions for treatment/prevention of graft rejection (2018-08-07),

7. 10039787 - Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases (2018-08-07),

8. 10039786 - Acellular pro-tolerogenic compositions and process for making same (2018-08-07),

9. 9579367 - C-terminally tethered amino acids and their fibrinolytic therapeutic uses (2017-02-28),

10. 9134336 - Dual analyzer system for biological fluid (2015-09-15),

11. 9134206 - Container for non-invasive fluid sample access (2015-09-15),

12. 8877458 - Method of detecting bacterial contamination using dynamic light scattering (2014-11-04),

13. 8835129 - Dynamic light scattering for in vitro testing of bodily fluids (2014-09-16),

14. 8728735 - Method for the simultaneous determination of blood group and platelet antigen genotypes (2014-05-20),

15. 8673566 - [object Object] (2014-03-18),

Company Overview

Canadian Blood Services is a national organization dedicated to managing the blood supply in Canada. It specializes in the collection, testing, processing, and distribution of blood and blood products, ensuring a safe and reliable supply for patients in need. The organization also focuses on research and innovation in transfusion medicine and cellular therapies, contributing to advancements in patient care. With a commitment to public health, Canadian Blood Services operates across the country, collaborating with healthcare partners to enhance the effectiveness of blood donation and utilization.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

33 Patents

#27 in Ottawa

#408 in Canada

#20,190 in the World

Canadian Blood Services

Forward Citations = 97

37 inventors:

Elisabeth Maurer (9 out of 13 patents)

Mark D Scott (9 out of 11 patents)

Duncheng Wang (5 out of 7 patents)

4. Wendy M Toyofuku (5 out of 7 patents)

5. Alan H Lazarus (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Canadian Blood Services. Retrieved from https://idiyas.com/company/canadian-blood-services

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…